Company

SpyGlass Ophthalmics Inc.

SpyGlass Ophthalmics develops treatments for chronic eye diseases.

About

SpyGlass Ophthalmics develops therapeutic technologies for chronic ophthalmic diseases. Founded in 2019, the company is based in Mission Viejo, US. On December 29, 2020, it raised USD 27.5 mn in Series B funding led by Vensana Capital, with participation from New Enterprise Associates and other investors.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in